tiprankstipranks
Trending News
More News >
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
US Market
Advertisement

Oramed Pharm (ORMP) Financial Statements

Compare
523 Followers

Oramed Pharm Financial Overview

Oramed Pharm's market cap is currently $84.47M. The company's EPS TTM is $-0.476; its P/E ratio is 21.10; Oramed Pharm is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 1.34M$ 2.70M$ 2.70M$ 2.71M
Gross Profit$ -193.00K$ 1.34M$ 2.70M$ 2.70M$ 2.62M
Operating Income$ -12.78M$ -15.77M$ -40.60M$ -24.22M$ -11.76M
EBITDA$ -14.87M$ -15.57M$ -36.98M$ -25.04M$ -11.31M
Net Income$ -19.10M$ 5.53M$ -37.76M$ -22.24M$ -11.51M
Balance Sheet
Cash & Short-Term Investments$ 141.93M$ 162.05M$ 155.72M$ 94.14M$ 39.90M
Total Assets$ 155.28M$ 220.55M$ 161.64M$ 128.00M$ 44.63M
Total Debt$ 372.00K$ 51.62M$ 894.00K$ 533.00K$ 75.00K
Net Debt$ -54.05M$ 42.57M$ -39.57M$ -76.71M$ -19.22M
Total Liabilities$ 9.93M$ 57.66M$ 10.49M$ 11.48M$ 11.75M
Stockholders' Equity$ 146.26M$ 163.82M$ 151.81M$ 115.77M$ 32.88M
Cash Flow
Free Cash Flow$ -8.43M$ -10.55M$ -28.41M$ -21.56M$ -12.52M
Operating Cash Flow$ -8.41M$ -10.29M$ -27.92M$ -21.18M$ -12.44M
Investing Cash Flow$ 105.82M$ -73.04M$ 30.21M$ -23.76M$ 4.63M
Financing Cash Flow$ -52.04M$ 51.98M$ 10.78M$ 102.89M$ 23.79M
Currency in USD

Oramed Pharm Earnings and Revenue History

Oramed Pharm Debt to Assets

Oramed Pharm Cash Flow

Oramed Pharm Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis